{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:49:02Z","timestamp":1774579742882,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,9]]},"DOI":"10.7759\/cureus.101146","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:26:53Z","timestamp":1767954413000},"source":"Crossref","is-referenced-by-count":1,"title":["Precision Health Optimization Program in the Management of Advanced Parkinson\u2019s Disease: A Case Series"],"prefix":"10.7759","author":[{"given":"G","family":"Niraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Charan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Niraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha B","family":"Karanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmanan","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong MJ","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020, 323:548-60. 10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem BR","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021, 397:2284-303. 10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00219-2","article-title":"Parkinson's disease outside the brain: targeting the autonomic nervous system","volume":"20","author":"Sharabi Y","year":"2021","unstructured":"Sharabi Y, Vatine GD, Ashkenazi A. Parkinson's disease outside the brain: targeting the autonomic nervous system. Lancet Neurology. 2021, 20:868-76. 10.1016\/S1474-4422(21)00219-2","journal-title":"Lancet Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03443","article-title":"A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases","volume":"120","author":"Mandemakers W","year":"2007","unstructured":"Mandemakers W, Morais VA, De Strooper B. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci. 2007, 120:1707-16. 10.1242\/jcs.03443","journal-title":"J Cell Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/mi.2025.267","article-title":"Epidemiology of autonomic dysfunction in Parkinson's disease (review)","volume":"5","author":"Rissardo JP","year":"2025","unstructured":"Rissardo JP, Gadelmawla AF, Khalil I, Abdulgadir A, Bhatti KS, Fornari Caprara AL. Epidemiology of autonomic dysfunction in Parkinson's disease (review). Med Int (Lond). 2025, 5:68. 10.3892\/mi.2025.267","journal-title":"Med Int (Lond)"},{"key":"ref6","unstructured":"National Institute of Naturopathy. (2025). Accessed. January 9, 2026: https:\/\/ninpune.ayush.gov.in\/#!\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2024-0071","article-title":"Stellate ganglion block in disparate treatment-resistant mental health disorders: a case series","volume":"25","author":"Niraj G","year":"2025","unstructured":"Niraj G, Karanth V, Niraj S, Charan N. Stellate ganglion block in disparate treatment-resistant mental health disorders: a case series. Scand J Pain. 2025, 25:10.1515\/sjpain-2024-0071","journal-title":"Scand J Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2010.58.1.56","article-title":"The changes of heart rate variability after unilateral stellate ganglion block","volume":"58","author":"Kim JJ","year":"2010","unstructured":"Kim JJ, Chung RK, Lee HS, Han JI. The changes of heart rate variability after unilateral stellate ganglion block. Korean J Anesthesiol. 2010, 58:56-60. 10.4097\/kjae.2010.58.1.56","journal-title":"Korean J Anesthesiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2020.11.028","article-title":"Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients","volume":"53","author":"Zhu G","year":"2021","unstructured":"Zhu G, Kang Z, Chen Y, Zeng J, Su C, Li S. Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients. Dig Liver Dis. 2021, 53:581-6. 10.1016\/j.dld.2020.11.028","journal-title":"Dig Liver Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2019.07.003","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling","volume":"49","author":"Wu Y","year":"2019","unstructured":"Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019, 49:35-45. 10.1016\/j.mito.2019.07.003","journal-title":"Mitochondrion"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/01635589709514513","article-title":"Effect of antioxidant vitamin supplementation on DNA damage and repair in human lymphoblastoid cells","volume":"27","author":"Sweetman SF","year":"1997","unstructured":"Sweetman SF, Strain JJ, McKelvey-Martin VJ. Effect of antioxidant vitamin supplementation on DNA damage and repair in human lymphoblastoid cells. Nutr Cancer. 1997, 27:122-30. 10.1080\/01635589709514513","journal-title":"Nutr Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320722","article-title":"A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease","volume":"32","author":"Fahn S","year":"1992","unstructured":"Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann Neurol. 1992, 32:128-32. 10.1002\/ana.410320722","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000150865.21759.bc","article-title":"The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease","volume":"27","author":"Nagayama H","year":"2004","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2004, 27:270-3. 10.1097\/01.wnf.0000150865.21759.bc","journal-title":"Clin Neuropharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1595568","article-title":"A clinical study on ozone autohemotherapy for the treatment of acute ischemic stroke","volume":"12","author":"Cheng H","year":"2025","unstructured":"Cheng H, Lu R, Du J, Zhao X, Zhuang Z. A clinical study on ozone autohemotherapy for the treatment of acute ischemic stroke. Front Med (Lausanne). 2025, 12:1595568. 10.3389\/fmed.2025.1595568","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4081\/ozone.2018.7511","article-title":"New frontiers in rehabilitation. Oxygen-ozone therapy and neuronal plasticity in the treatment of Parkinson's symptoms","volume":"3","author":"Morelli L","year":"2018","unstructured":"Morelli L, Bramani SC, Guarino A. New frontiers in rehabilitation. Oxygen-ozone therapy and neuronal plasticity in the treatment of Parkinson's symptoms. Ozone Therapy. 2018, 3:10.4081\/ozone.2018.7511","journal-title":"Ozone Therapy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11517-016-1580-z","article-title":"Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients","volume":"55","author":"Molinari F","year":"2017","unstructured":"Molinari F, Rimini D, Liboni W, et al.. Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients. Med Biol Eng Comput. 2017, 55:1163-75. 10.1007\/s11517-016-1580-z","journal-title":"Med Biol Eng Comput"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01824-0","article-title":"Beyond Paradox: ozone therapy as a hormetic modulator in ischemia-reperfusion injury - an update","volume":"83","author":"Ye Y","year":"2025","unstructured":"Ye Y, Yu ZH, Nie L, Wang FX, Mu G. Beyond Paradox: ozone therapy as a hormetic modulator in ischemia-reperfusion injury - an update. Cell Biochem Biophys. 2025, 83:4163-80. 10.1007\/s12013-025-01824-0","journal-title":"Cell Biochem Biophys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/2045-9912.239959","article-title":"Emerging mechanisms and novel applications of hydrogen gas therapy","volume":"8","author":"Matei N","year":"2018","unstructured":"Matei N, Camara R, Zhang JH. Emerging mechanisms and novel applications of hydrogen gas therapy. Med Gas Res. 2018, 8:98-102. 10.4103\/2045-9912.239959","journal-title":"Med Gas Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2009.02.016","article-title":"Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease","volume":"453","author":"Fu Y","year":"2009","unstructured":"Fu Y, Ito M, Fujita Y, et al.. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett. 2009, 453:81-5. 10.1016\/j.neulet.2009.02.016","journal-title":"Neurosci Lett"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05489-4","article-title":"Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study","volume":"42","author":"Yoritaka A","year":"2021","unstructured":"Yoritaka A, Kobayashi Y, Hayashi T, Saiki S, Hattori N. Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson's disease: a pilot study. Neurol Sci. 2021, 42:4767-70. 10.1007\/s10072-021-05489-4","journal-title":"Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450003-precision-health-optimization-program-in-the-management-of-advanced-parkinsons-disease-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:26:53Z","timestamp":1767954413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450003-precision-health-optimization-program-in-the-management-of-advanced-parkinsons-disease-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.101146","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}